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Abstract
Background: To accurately assess micronutrient status, it is necessary to characterize the effects 
of inflammation and the acute-phase response on nutrient biomarkers.
Objective: Within a norovirus human challenge study, we aimed to model the inflammatory 
response of C-reactive protein (CRP) and α-1-acid glycoprotein (AGP) by infection status, model 
kinetics of micronutrient biomarkers by inflammation status, and evaluate associations between 
inflammation and micronutrient biomarkers from 0 to 35 d post–norovirus exposure.
Methods: Fifty-two healthy adults were enrolled into challenge studies in a hospital setting and 
followed longitudinally; all were exposed to norovirus, half were infected. Post hoc analysis of 
inflammatory and nutritional biomarkers was performed. Subjects were stratified by inflammation 
resulting from norovirus exposure. Smoothed regression models analyzed the kinetics of CRP and 
AGP by infection status, and nutritional biomarkers by inflammation. Linear mixed-effects models 
were used to analyze the independent relations between CRP, AGP, and biomarkers for iron, 
vitamin A, vitamin D, vitamin B-12, and folate from 0 to 35 d post–norovirus exposure.
Results: Norovirus-infected subjects had median (IQR) peak concentrations for CRP [16.0 (7.9–
29.5) mg/L] and AGP [0.9 (0.8–1.2) g/L] on day 3 and day 4 postexposure, respectively. 
Nutritional biomarkers that differed (P < 0.05) from baseline within the inflamed group were 
ferritin (elevated day 3), hepcidin (elevated days 2, 3), serum iron (depressed days 2–4), transferrin 
saturation (depressed days 2–4), and retinol (depressed days 3, 4, and 7). Nutritional biomarker 
concentrations did not differ over time within the uninflamed group. In mixed models, CRP was 
associated with ferritin (positive) and serum iron and retinol (negative, P < 0.05).
Conclusion: Using an experimental infectious challenge model in healthy adults, norovirus 
infection elicited a time-limited inflammatory response associated with altered serum 
concentrations of certain iron and vitamin A biomarkers, confirming the need to consider 
adjustments of these biomarkers to account for inflammation when assessing nutritional status. 
These trials were registered at clinicaltrials.gov as and .
Keywords
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Introduction
Describing the relation between acute-phase proteins (APPs) and nutritional biomarkers in 
settings with high infectious disease burden is necessary for accurate assessment of 
micronutrient status (1). If underlying inflammation is ignored, iron and vitamin A status 
may be misclassified (2, 3). Within nationally representative surveys of children 6–59 mo 
old, misclassification ranged from underestimating iron deficiency by a median 25 
percentage points (4) to overestimating vitamin A deficiency by a median 16 percentage 
points (5). Evaluation of nutrition programs or interventions may also be confounded by 
inflammation, specifically when they are combined with interventions targeted to reduce 
infection (6–8).
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Currently, the only biomarker for which there is a consensus global guideline for adjustment 
in the context of inflammation is serum ferritin (9). The evidence base for adjusting 
nutritional biomarkers in the context of inflammation is limited to cross-sectional meta-
analyses (10,11), and a few longitudinal studies of adults undergoing surgery (12) or 
experiencing severe infections (13). Thus, an accurate assessment of micronutrient status 
depends on additional evidence quantifying time-varying interactions between nutritional 
biomarkers and infectious disease burden.
To assess patterns and interactions of inflammatory and nutritional biomarkers in response to 
an infectious challenge, we leveraged longitudinal data collected from 2 norovirus challenge 
trials (14, 15). Norovirus is the most common cause of diarrheal disease (16, 17), associated 
with 18% of diarrheal disease globally (18, 19). Although infections trigger an innate 
inflammatory response that temporarily alters circulating APPs (1, 11, 20), the kinetics of 
APPs triggered by exposure to norovirus has not been characterized. Iron and vitamin A 
biomarkers have been shown to be affected by subclinical levels of inflammation (5, 21–24), 
which may be better represented by the APP response to norovirus than a more severe 
infection, such as typhoid (13).
Our goal was to characterize the inflammatory response after a norovirus challenge, and to 
characterize the time-varying nutritional biomarker fluctuations by inflammatory response 
status. Our specific objectives were to model the kinetics of C-reactive protein (CRP) and 
α-1-acid glycoprotein (AGP) stratified by infection status, and to model the kinetics of 
micronutrient biomarkers [ferritin, hepcidin, serum iron, soluble transferrin receptor (sTfR), 
transferrin concentration, transferrin saturation, retinol-binding protein (RBP), retinol, 25-
hydroxyvitamin D [25(OH)D], vitamin B-12, and folate] stratified by inflammation status. 
We hypothesized that CRP and AGP concentrations would differ by infection status, and that 
some micronutrient biomarker concentrations would differ by inflammation status resultant 
from norovirus exposure [ferritin ↑, hepcidin ↑, serum iron ↓, RBP ↓, retinol ↓, 25(OH)D ↓], 
whereas others would remain static (sTfR, vitamin B-12, and folate). We further evaluated 
the independent associations between CRP, AGP, and micronutrient biomarkers from 0 to 35 
d postexposure.
Methods
Subjects and ethics
The serum assayed for this study was collected from apparently healthy adults that 
participated in 1 of 2 independent longitudinal norovirus challenge trials ( and ) conducted at 
a Clinical Research Center in the United States between 2006 and 2009, and outcomes from 
those trials have been published (14, 15). The trials shared a common design and had similar 
protocols for specimen collection and participant assessment; however, they had different 
inoculum doses of 8FIIb Norwalk virus (HuNoV genogroup GI.1, ~6.5 × 107 genomic 
equivalent copies per milliliter from 10 mL spiked groundwater or 1 × 104 genomic 
equivalent copies of virus from infected oysters) (14, 15). In brief, healthy volunteers were 
challenged with the virus, observed in controlled conditions in a hospital setting for 4 d, and 
then discharged with instructions to return on days 7, 14, 21, 28, and 35 postchallenge. 
Serum was collected every day during the hospital stay and at each follow-up visit. Serum 
Williams et al. Page 3
Am J Clin Nutr. Author manuscript; available in PMC 2019 December 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
was stored in −80°C freezers for 7–10 y until they were shipped on dry ice to laboratories 
for the biomarker assessments of this study. Emory University Institutional Review Board 
approved both trials.
Of 64 enrolled volunteers, 26 became infected [norovirus was detectable in stool by real-
time PCR (RT-PCR)] and among the infected 19 were symptomatic. A subsequent case-
control study was conducted to describe the cytokine response patterns from norovirus 
exposure in 52 of the volunteers (25). We analyzed biomarkers from the same 52 subjects 
(age-matched, balanced by infection status) that had been sampled for the cytokine study 
(Supplemental Figure 1). The repeated-visits study design enabled assessing kinetics of 
CRP, AGP, and selected nutritional biomarkers. The nutritional biomarkers are ordered 
throughout the article in ascending order of existing evidence pertaining to their relation 
between nutrient and inflammation (1): iron [ferritin, hepcidin, iron, transferrin (receptor, 
saturation, and concentration)], vitamin A (RBP and retinol), vitamin D [25(OH)D], folate, 
and vitamin B-12.
Laboratory methods
Sandwich ELISA was used to measure CRP, AGP, ferritin, sTfR, and RBP at the VitMin 
laboratory (26). Serum hepcidin was quantified using the Hepcidin-25 (Bioactive) HS 
ELISA kit (DRG International, Inc.) according to the manufacturer’s protocol in a 
laboratory at Oxford University. Serum iron and transferrin concentrations were quantified 
using automated assays on an Abbott Architect c16000 automated analyzer (Abbott 
Laboratories) in the same lab that assessed hepcidin. Serum retinol (200 μL) was measured 
using HPLC in isocratic mode with 95:5 methanol:water (10 mM ammonium acetate) at 1 
mL/min in a laboratory at the University of Wisconsin-Madison. Serum 25(OH)D was 
measured using the Immunodiagnostic Systems iSYS chemiluminescent assay in a 
laboratory at Emory University participating in the vitamin D External Quality Assessment 
Scheme. Folate concentrations were measured in serum using the microbiological assay at 
the Instituto de Investigación Nutricional in Lima, Peru. Serum vitamin B-12 was analyzed 
using a Cobas e411 (Roche Diagnostics) with a competitive protein binding 
chemiluminescence immunoassay at the Western Human Nutrition Research Center in 
Davis, CA. Both the VitMin and Instituto de Investigación Nutricional laboratories 
participate in the US CDC’s external laboratory quality assurance program VITAL-EQA 
(27).
Variable descriptions
All biomarkers were used as continuous variables in the kinetic modeling. Micronutrient and 
inflammation cutoffs were applied to define deficiency and to categorize subjects with 
inflammation due to norovirus exposure. The following cutoffs were applied: ferritin <15 
μg/L (9), retinol <0.7 μmol/L (28), 25(OH)D <12 ng/mL (29), serum folate <10 nmol/L 
(30), vitamin B-12 <150 pmol/L (31), CRP >5 mg/L, and AGP >1 g/L (1). Binary clinical 
inflammation resulting from norovirus exposure was determined by comparing baseline (day 
0, before norovirus exposure) CRP and AGP concentrations with days 1–3 CRP and AGP 
concentrations. Subjects with inflammatory biomarkers exceeding commonly used 
thresholds to define inflammation (CRP >5 mg/L or AGP >1 g/L) (1) on day 0 were 
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considered inflamed at baseline. Those inflamed at baseline were excluded from analyses 
because our objective was to assess the effect of inflammation resulting from norovirus 
exposure. Clinical inflammation resulting from norovirus exposure was defined as CRP >5 
mg/L or AGP >1 g/L at any time 1–3 d postexposure. Subjects were defined as symptomatic 
if after the norovirus exposure they experienced diarrhea, vomiting, or ≥1 of the following 
self-reported characteristics: nausea, abdominal cramps, headache, chills, myalgia, or fatigue 
(32).
Statistical analysis
All data processing and analyses were conducted in R version 3.4.3 (R Core Team) using the 
“dplyr,” “nlme,” “dunn.test,” and “ggplot2” packages. Baseline characteristics were 
compared across infection and inflammation status, separately, using χ2 and Kruskal–Wallis 
tests for categorical and continuous measures, respectively. To characterize the inflammatory 
response of norovirus infection, the Kruskal–Wallis test was used to compare differences in 
median APP concentrations at days 1, 2, 3, 4, 7, 14, 21, and 35 by infection status. If any of 
the median tests indicated significant differences, then pairwise comparisons between each 
time point and baseline concentration were compared using Dunn’s test with correction for 
multiple comparisons. To characterize the nutritional biomarker fluctuations by 
inflammatory response status, the Kruskal–Wallis test was used to compare differences in 
median concentration of nutritional biomarkers at each time point postinfection, stratified by 
inflammation status. Similarly, Dunn’s test was used to compare differences between 
baseline and time points that differed between inflamed and uninflamed groups. 
Concentrations of biomarkers over time were modeled using local regressions (locally 
estimated scatterplot smoothing) to provide a smoothed visual of temporal trends.
To evaluate the independent associations between APPs and each nutritional biomarker, we 
constructed time-lagged models of inflammation effects and autocorrelation of the prior 
measurement of nutritional biomarkers. All nutritional biomarkers were natural log–
transformed to model these associations. Linear mixed-effect models were constructed for 
each nutritional biomarker outcome separately. The temporal effects and autocorrelation 
were explicitly modeled using time-lagged concentrations, i.e., CRPt–i, where t is the current 
measurement of a biomarker concentration and i represents a previous measure. Initially, 
autocorrelation was assessed within subjects using the function “acf” for ≤10 previous 
measurements. A majority of biomarkers had the strongest correlations within days 1–4; 
therefore, lagged variables were created and fit up to t – 4. Each model included all time 
points, and was fit using backwards selection through assessing model fit statistics, i.e., 
Akaike Information Criterion and log likelihood, coefficients, and SEs.
The full model took the form:
lnY t = α + θ + CRPt + CRPt − 1 + CRPt − 2 + CRPt − 3 + CRPt − 4 + AGPt
+ AGPt − 1 + AGPt − 2 + AGPt − 3 + AGPt − 4 + lnY t − 1 + ε
(1)
where Yt is the nutritional biomarker concentration at measurement time t, α is the fixed 
intercept, θ is the subject random-effect intercept as N(τ2 = 0), and ε is the residual model 
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error as N(σ2 = 0). The acute-phase inflammation biomarkers CRP and AGP are included at 
time t as CRPt and AGPt. Lags are denoted as subtractions from t, e.g., CRPt−3.
Results
Participant characteristics
One infected subject was dropped owing to incomplete data. The median (IQR) age of study 
subjects was 25 (21–28) y old, and baseline temperature, pulse, respiration, and blood 
pressure indicated no evidence of acute illness. Baseline micronutrient deficiencies were 
absent for retinol (<0.7 μmol/L) and vitamin B-12 (<150 pmol/L). Six percent of subjects 
had folate deficiency (<10 nmol/L), 14% were at risk of vitamin D deficiency [25(OH)D 
<12 ng/mL], and 16% had low iron stores (serum ferritin <15 μg/L). Median vitamin B-12 
concentration at baseline was significantly higher among subjects that became infected with 
norovirus than among noninfected subjects (Supplemental Table 1). Baseline nutritional 
profiles and APP concentrations did not differ between subjects stratified by clinical 
inflammation resulting from norovirus exposure (Table 1).
Six subjects with inflammatory biomarkers above thresholds commonly used to define 
inflammation at baseline (4 with elevated CRP, 2 with elevated AGP) were excluded from all 
analyses beyond the descriptive statistics. Clinical inflammation resulting from norovirus 
exposure did not correlate perfectly with norovirus infection, defined by norovirus 
detectable in stool by RT-PCR. The majority of subjects that demonstrated clinical 
inflammation resulting from norovirus exposure were infected with norovirus (n = 20 of 21, 
or 95%; Table 2). However, of the 24 noninflamed subjects, 3 people were norovirus 
infected (detectable in stool by RT-PCR), although they were asymptomatic.
APP response to norovirus infection
The inflammatory response of CRP and AGP serum concentrations was modeled by 
norovirus infection status. There were similarities between CRP and AGP peak 
concentrations as well as normalization time among norovirus-infected individuals (Figure 
1). CRP peaked with a median (IQR) concentration of 16.0 (7.9–29.5) mg/L at day 3, and 
AGP peaked at 0.9 (0.8–1.2) g/L at day 4 for the infected group. At day 3, both APPs were 
significantly different from the uninfected group (CRP: χ2K–W = 21.5, P < 0.01; AGP: 
χ2K–W = 4.6, P < 0.01). CRP and AGP medians of the infected group were indistinguishable 
from the uninfected group by day 7 (χ2K–W = 1.5, P = 0.21; χ2K–W = 1.0, P = 0.30). Within 
the uninfected group, neither CRP nor AGP concentrations deviated from baseline (χ2K–W = 
6.9, P = 0.64; χ2K–W = 11.3, P = 0.24) over the study course (Figure 1).
Nutritional biomarker responses to inflammation caused by norovirus exposure
The kinetics of micronutrient biomarkers [ferritin, hepcidin, serum iron, sTfR, transferrin 
concentration, transferrin saturation, RBP, retinol, 25(OH)D, folate, and vitamin B-12] were 
stratified by clinical inflammation resulting from norovirus exposure. Concentrations of the 
following nutrient biomarkers differed significantly compared with baseline concentrations 
among subjects that experienced inflammation from norovirus exposure: ferritin (elevated 
day 3, P < 0.05), hepcidin (elevated days 2–3, P < 0.01), serum iron (depressed days 2–4, P 
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< 0.01), transferrin saturation (depressed days 2–4, day 2 P < 0.05, day 3–4 P < 0.01), and 
retinol (depressed days 3, 4, and 7, P < 0.05; Figure 2). Although fluctuations in 
concentrations of the remaining nutritional biomarkers can be observed visually, there were 
no time points that differed in statistical significance from baseline concentration for sTfR, 
transferrin concentration, RBP, 25(OH)D, folate, or vitamin B-12 among the inflamed group 
(Figure 2). Among the uninflamed group, regardless of infection status, no nutritional 
biomarkers had concentrations that were statistically significantly different from baseline.
Independent effects of inflammation on nutritional biomarkers
Based on the most conservative models, adjusting for lagged inflammation effects and 
autocorrelation of the prior measurement of nutritional biomarkers for all subjects across 
time (Yt−1), ferritint, serum iront, sTfRt, retinolt, RBPt, and vitamin B-12t were 
independently associated with CRPt or AGPt (Table 3). The iron biomarkers ferritint (β: 
0.11; 95% CI: 0.06, 0.15) and serum iront (β: −0.10; 95% CI: −0.19, −0.01) were 
significantly associated with CRPt. sTfRt was significantly positively associated with AGPt 
(0.10; 95% CI: 0.08, 0.13) and negatively associated with CRPt (β: −0.06; 95% CI: −0.08, 
−0.03). The vitamin A biomarkers retinolt (β: −0.05; 95% CI: −0.07, −0.04) and RBPt (β: 
−0.07; 95% CI: −0.09, −0.05) were significantly negatively associated with CRPt. RBPt was 
also significantly positively associated with AGPt (β: 0.04; 95% CI: 0.02, 0.06). Vitamin 
B-12t was significantly positively and negatively associated, respectively, with AGPt (β: 
0.03; 95% CI: 0.01, 0.05) and CRPt (β: −0.02; 95% CI: −0.04, −0.003) (Table 3). The 
coefficients for the lagged inflammation effects are included in Supplemental Table 2.
Discussion
Using an experimental infectious challenge model, we have demonstrated a clear causative, 
time-limited relation between acute inflammation and perturbations in micronutrient 
biomarkers of iron and vitamin A status, confirming the need to consider adjustments of 
these biomarkers to account for inflammation when assessing nutritional status. Norovirus 
induced an inflammatory response (demonstrated by elevations in CRP and AGP) 3–4 d 
after exposure, which caused elevations in serum ferritin and hepcidin, and reductions in 
serum iron and retinol, concentrations. These perturbations were supported by the 
independent positive association between ferritin and CRP, and the independent negative 
associations between serum iron, retinol, and CRP in linear mixed models. No nutritional 
biomarker perturbations were observed over the 35-d study duration among uninflamed 
subjects, further supporting that the concentration changes seen among the inflamed group 
were likely artificial and not reflecting true nutrition status alterations.
Inflammatory protein response to norovirus infection
CRP has been described as the “first line of innate host defense” for decades (33–36). 
Although animal models have characterized CRP kinetics (37), there are limited studies in 
humans. Furthermore, most investigations have modeled CRP kinetics under extreme 
conditions, such as surgeries (12, 38). As evident from recent meta-analyses, nutritional 
biomarkers are affected by even low levels of inflammation in both high and low infection 
burden settings (5, 21–24), raising the question of APP patterns during common, self-
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limiting infections. In our trial, norovirus infection triggered an acute-phase response as 
indicated by median peak concentrations of 16.0 mg CRP/L at day 3 postexposure, >3 times 
the usual CRP cutoff (5 mg/L). However, the median peak concentration of AGP (0.9 g/L) at 
day 4 was lower than the traditionally used cutoff of AGP of 1 g/L. In a controlled typhoid 
experiment among apparently healthy adults, CRP peaked 2 d after diagnosis, with a median 
concentration >100 mg/L (13). Two to 3 d after elective orthopedic surgery, CRP reached a 
maximum concentration, ranging from 48 to 140 mg/L (38). CRP has demonstrated 
increases >1000-fold post–inflammatory stimuli (39). Evidence of AGP kinetics during 
infection or in response to tissue injury is limited, compared with CRP. However, there has 
been a general recognition that AGP rises more slowly than CRP and stays elevated for a 
longer period of time (40), although this pattern was not observed in this study.
Nutritional biomarker responses to inflammation caused by norovirus exposure
Although the kinetics we observed for CRP and AGP in response to norovirus infection 
were distinct from typical thresholds used to describe the acute-phase response (10, 22, 41, 
42), the iron and vitamin A responses to inflammation were as hypothesized. Marked 
reductions in circulating iron (serum iron and transferrin saturation) (43–45) were likely 
caused by the observed induction of the hormonal iron regulator, hepcidin, and the iron 
storage protein ferritin also increased. The hepcidin concentration peaked (day 2 
postexposure) before the ferritin peak (day 3 postexposure). Similar to other APPs, hepcidin 
is upregulated during the innate response to infection via the IL6/signal transducer and 
activator of transcription 3 pathway (46, 47). An increase in hepcidin concentrations after 
pathogen exposure has been likewise demonstrated in other human infection challenge 
studies, including typhoid (13) and malaria (48, 49). The vitamin A biomarkers, RBP and 
retinol, demonstrated similar responses to inflammation: retinol concentrations were 
statistically lower than baseline on days 3, 4, and 7 post–exposure to norovirus, and RBP 
followed a similar pattern that was observed visually, but was not statistically significant, 
possibly owing to small sample size or a modest inflammatory response. This depression of 
vitamin A biomarkers coinciding with elevated inflammatory proteins has been 
demonstrated in numerous studies (50–52). Concentrations of sTfR, transferrin, 25(OH)D, 
folate, and vitamin B-12 did not differ over time within the inflamed group. Among the 
uninflamed group, none of the nutritional biomarker concentrations differed over time, 
indicating that the nutritional biomarker perturbations seen among the inflamed group were 
likely artificial and not reflecting true nutrition status alterations.
The lower vitamin B-12 concentrations at baseline that appeared protective of norovirus 
infection may have a genetic explanation, such as a single nucleotide polymorphism. 
Although secretor-positive adults were enrolled into these challenge studies (32), genetic 
variants of fucosyltransferase 2 (FUT2) have been associated with lower vitamin B-12 status 
(53, 54). Homozygous FUT2 nonsecretor genotype is characterized as resistant to norovirus 
infection (55, 56).
Independent effects of inflammation on nutritional biomarkers
The independent associations of ferritin, serum iron, and retinol with CRP at time t support 
the causal framework that inflammation affects iron and vitamin A metabolism. However, 
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the combination of assessing CRP and AGP simultaneously adds complexity to this analysis 
and interpretation. For example, sTfR, RBP, and vitamin B-12 all had significant direct 
associations with CRP and significant inverse associations with AGP at time t, possibly due 
to distinct roles of the APPs that result in nutrient sequestration that varies across time. As 
demonstrated by Wessells et al. (57), accounting for the temporal effects of inflammation 
resulted in more subtle corrections for inflammation than cross-section-based techniques. 
Having access to repeated measures on individuals within surveys to estimate the effects of 
inflammation on micronutrient biomarkers may be rare, but additional analysis of existing 
cohort data sets that contain nutrition and inflammation biomarkers would help elucidate 
these complex interactions.
Strengths and limitations
Our study is one of the first to assess dynamic changes in inflammation and micronutrient 
biomarkers after an experimental enteric viral challenge. We quantified the kinetics of APPs 
given norovirus infection, and the subsequent effects of inflammation on nutrient 
biomarkers, providing clear indication that nutrient biomarkers fluctuate during relatively 
mild infections among adults. The strengths of this analysis were the repeated-measures 
design and the controlled norovirus challenge with serum samples utilized at 10 time points. 
A limitation of this analysis was that results from adults cannot be directly transferred to 
children. The population group of highest concern for nutritional status misclassification and 
norovirus infections are children <5 y of age; however, our challenge studies were 
performed on apparently healthy adults. The immune system maturation likely influences 
the inflammation and nutritional biomarker kinetic response to norovirus exposure. 
Therefore, patterns might be more pronounced in children. Another limitation was the small 
sample size. In some cases such as RBP, changes in nutritional biomarker concentrations 
seemed apparent graphically, yet the studies were likely underpowered and did not reach 
statistical significance. The inflammation lag terms in the linear mixed model may have 
been easier to interpret within a larger sample as well.
Conclusions
The confounding effects of inflammation on micronutrient biomarkers have been identified 
as a critical research gap (1), and efforts to adjust nutrition biomarkers for inflammation 
have been limited to cross-sectional data (11, 22, 42, 58). This study demonstrates that some 
people exposed to norovirus do not experience virus in their stools or elevated APPs. 
Inflammation from norovirus affects the measurement concentrations of some iron and 
vitamin A biomarkers, and therefore should be interpreted accordingly.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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FIGURE 1. 
Baseline (day 0) to day 35 postexposure CRP (A) and AGP (B) measurements plotted using 
box and whiskers, displaying median and IQR (box range) with whiskers representing 1.5 × 
the 25% and 75% quartile and outliers depicted by dots (n = 45 subjects with repeated 
measures). Pairwise differences between baseline and other days within infection grouping 
tested using Dunn’s test. Box plot locally estimated scatterplot smoothing fit with 95% 
prediction interval in black and gray banding. AGP, α-1-acid glycoprotein; CRP, C-reactive 
protein.
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FIGURE 2. 
Baseline (day 0) to day 35 postexposure nutritional biomarker measurements plotted using 
box and whiskers, displaying median and IQR (box range) with whiskers representing 1.5 × 
the 25% and 75% quartile and outliers depicted by dots (n = 45 subjects with repeated 
measures). Pairwise differences between baseline and other days within infection grouping 
tested using Dunn’s test. Box plot locally estimated scatterplot smoothing fit with 95% 
prediction interval in black and grey banding. RBP, retinol-binding protein; sTfR, soluble 
transferrin receptor; TSAT, transferrin saturation; 25(OH)D, 25-hydroxyvitamin D.
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TABLE 2
Comparison of subject classifications for inflamed, norovirus infected, and symptomatic within a norovirus 
human challenge study1
Inflamed
Classification Yes No Total
Norovirus infected and symptomatic 16 0 16
Norovirus infected and asymptomatic 4 3 7
Norovirus uninfected and symptomatic 0 2 2
Norovirus uninfected and asymptomatic 1 19 20
Total 21 24 45
1
Inflammation resulting from norovirus exposure was defined as CRP >5 mg/L or AGP >1 g/L at any time 1–3 d postexposure, given CRP ≤5 
mg/L and AGP ≤1 g/L on day 0. Six subjects were excluded based on CRP >5 mg/L or AGP >1 g/L on day 0. Norovirus infection was defined as 
norovirus detectable in stool by real-time PCR. Symptomatic was defined as diarrhea, vomiting, or ≥1 of the following self-reported characteristics: 
nausea, abdominal cramps, headache, chills, myalgia, or fatigue. AGP, α-1-acid glycoprotein; CRP, C-reactive protein.
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